Blog
Articles, guides, and regulatory updates from our community.
GLP-1 Drugs and Skin Health: What Research Shows
New research explores how GLP-1 receptor agonists affect skin biology, inflammation, wound healing, and aesthetic aging. Learn what the evidence shows.
By Peptide Association Research Team
Injectable Peptides in Sports Medicine: What Research Shows
A 2026 review in JBJS Reviews examines the evidence, safety, and antidoping implications of injectable peptides used in sports medicine and orthopaedics.
By Peptide Association Research Team
How Peptide Therapy Is Transforming Weight Management
The GLP-1 revolution has rewritten the rules of obesity treatment. How incretin-based peptide therapies achieve what diet and exercise alone cannot — and what comes next.
By Peptide Association Editorial Team
Semaglutide vs Tirzepatide: Comparing GLP-1 Therapies
A head-to-head comparison of the two leading GLP-1 receptor agonists — mechanisms of action, clinical trial data, side effects, and practical considerations for providers and patients.
By Peptide Association Editorial Team